Group Dinner Meeting to be held in Boston on October 29 hosted by Cantor.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- Beam Therapeutics Advances BEAM-302 Study for AATD: Key Insights for Investors
- Video: This stock is dragging down the in vivo gene editing therapy space
- Beam Therapeutics’ BEAM-301 Study: A Promising Step in Rare Disease Treatment
- Beam Therapeutics’ BEACON Trial: A New Hope for Sickle Cell Disease
- Intellia Therapeutics price target lowered to $30 from $36 at BofA